MetaCap

Greenwich LifeSciences Insider Trades

NASDAQ: GLSIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

16.53+1.39 (+9.18%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
13 · $586.33K
Sales
0 · $0
Shares bought / sold
40.80K / 0
Net activity
Net buying $586,328

Greenwich LifeSciences insider activity

Over the last 12 months, Greenwich LifeSciences insiders reported 13 transactions on SEC Form 4: 13 open-market purchases and 0 sales. Insiders bought $586,328 and sold $0 worth of stock, for net insider buying of $586,328. The most recent filing shows Patel Snehal (CEO and CFO) buying 700 shares at $13.10 on Jul 29, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GLSI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GLSI insider transactions

Greenwich LifeSciences insider transactions
DateInsiderTypeSharesValueFiling
Jul 29, 2026Patel SnehalCEO and CFOBuy700$9.17KForm 4
Jul 28, 2026Patel SnehalCEO and CFOBuy1,500$20.39KForm 4
Jul 27, 2026Patel SnehalCEO and CFOBuy1,500$20.43KForm 4
Jul 24, 2026Patel SnehalCEO and CFOBuy1,100$14.17KForm 4
Jul 23, 2026Patel SnehalCEO and CFOBuy2,500$32.85KForm 4
Jan 13, 2026Patel SnehalCEO and CFOBuy1,800$53.69KForm 4
Jan 12, 2026Patel SnehalCEO and CFOBuy2,900$79.87KForm 4
Dec 31, 2025Patel SnehalCEO and CFOBuy4,300$91.85KForm 4
Dec 30, 2025Patel SnehalCEO and CFOBuy2,900$63.02KForm 4
Dec 18, 2025Patel SnehalCEO and CFOBuy4,100$51.74KForm 4
Nov 25, 2025Patel SnehalCEO and CFOBuy4,600$38.50KForm 4
Nov 7, 2025Patel SnehalCEO and CFOBuy10,600$89.36KForm 4
Oct 31, 2025Patel SnehalCEO and CFOBuy2,300$21.30KForm 4
Apr 25, 2025Patel SnehalCEO and CFOBuy3,600$35.57KForm 4
Apr 17, 2025Patel SnehalCEO and CFOBuy5,400$48.49KForm 4
Apr 7, 2025Patel SnehalCEO and CFOBuy3,600$32.76KForm 4
Apr 4, 2025Patel SnehalCEO and CFOBuy5,500$48.02KForm 4
Jan 10, 2025Patel SnehalCEO and CFOBuy2,500$31.27KForm 4
Jan 7, 2025Patel SnehalCEO and CFOBuy1,800$24.75KForm 4
Jan 6, 2025Patel SnehalCEO and CFOBuy1,100$14.64KForm 4
Jan 3, 2025Patel SnehalCEO and CFOBuy3,400$44.03KForm 4
Jan 2, 2025Patel SnehalCEO and CFOBuy2,000$23.94KForm 4
Dec 31, 2024Patel SnehalCEO and CFOBuy2,400$27.26KForm 4
Dec 30, 2024Patel SnehalCEO and CFOBuy3,200$35.58KForm 4
Nov 21, 2024Thompson JayeVP Clinical Reg AffairsBuy1,000$12.91KForm 4
Sep 26, 2024Patel SnehalCEO and CFOBuy1,500$21.95KForm 4
Aug 12, 2024Thompson JayeVP Clinical Reg AffairsBuy800$11.08KForm 4
Aug 6, 2024Patel SnehalCEO and CFOBuy2,000$27.62KForm 4
Aug 5, 2024Patel SnehalCEO and CFOBuy5,500$72.49KForm 4
Aug 2, 2024Thompson JayeVP Clinical Reg AffairsBuy1,000$15.15KForm 4
Jul 23, 2024Patel SnehalCEO and CFOBuy1,500$23.84KForm 4
Jul 18, 2024Thompson JayeVP Clinical Reg AffairsBuy1,000$16.00KForm 4
Jun 13, 2024Patel SnehalCEO and CFOBuy174,825$2.50MForm 4
Apr 1, 2024Patel SnehalCEO and CFOBuy3,000$57.24KForm 4
Mar 22, 2024Patel SnehalCEO and CFOBuy2,500$49.95KForm 4
Mar 20, 2024Patel SnehalCEO and CFOBuy1,500$26.52KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related